MedTrace Logo

Turkish Adaptation, Validity and Reliability of Cravings for Rest and Volitional Energy Expenditure (CRAVE)

NCT05248958 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2022-09-09

No results posted yet for this study

Summary

The aim of this study is to adapt the Cravings for Rest and Volitional Energy Expenditure (CRAVE) scale to Turkish society and to make its validity and reliability in Turkish. The CRAVE scale developed by Stults-Kolehmainen et al assesses the intrinsic motivation required for sedentary behavior and participation in physical activity. It has 13 questions. CRAVE scale questions and questions in the data collection form will be prepared through the google surveys and will be sent to the participants via Whatsapp, Facebook, Instagram and e-mail. Participants will fill out the survey forms online. 130 participants will be included in the study. In order to evaluate the validity of the CRAVE, the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2), which can measure exercise behaviors and intrinsic motivation and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Conditions

  • Exercise
  • Motivation
  • Sedantary Activity

Interventions

OTHER

Turkish Validity and Reliability of The CRAVE Scale

The aim of this study is to adapt the Cravings for Rest and Volitional Energy Expenditure (CRAVE) scale to Turkish society and to make its validity and reliability in Turkish.

Sponsors & Collaborators

  • Istanbul Medeniyet University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-05
Primary Completion
2022-08-20
Completion
2022-09-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05248958 on ClinicalTrials.gov